SE7908520L - SYSTEM FOR ADMINISTRATION OF MEDICINAL PRODUCTS IN THE FORM OF MICROPARTICLES - Google Patents

SYSTEM FOR ADMINISTRATION OF MEDICINAL PRODUCTS IN THE FORM OF MICROPARTICLES

Info

Publication number
SE7908520L
SE7908520L SE7908520A SE7908520A SE7908520L SE 7908520 L SE7908520 L SE 7908520L SE 7908520 A SE7908520 A SE 7908520A SE 7908520 A SE7908520 A SE 7908520A SE 7908520 L SE7908520 L SE 7908520L
Authority
SE
Sweden
Prior art keywords
microparticles
administration
medicinal products
reproductive organs
female reproductive
Prior art date
Application number
SE7908520A
Other languages
Unknown language ( )
Swedish (sv)
Inventor
L R Beck
Jr C E Flowers
D R Cowsar
A C Tanquary
Original Assignee
Stolle Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Res & Dev filed Critical Stolle Res & Dev
Publication of SE7908520L publication Critical patent/SE7908520L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Microparticles for the treatment of the internal female reproductive organs, comprise microparticles of a pharmaceutical agent incorporated in a matrix material which is biocompatible and biologically degradable, said microparticles being capable of being transported after deposition in the vagina by the natural transport mechanism of the internal female reproductive organs across the cervix into the uterus.
SE7908520A 1978-10-17 1979-10-15 SYSTEM FOR ADMINISTRATION OF MEDICINAL PRODUCTS IN THE FORM OF MICROPARTICLES SE7908520L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95210978A 1978-10-17 1978-10-17
US96738078A 1978-12-07 1978-12-07

Publications (1)

Publication Number Publication Date
SE7908520L true SE7908520L (en) 1980-04-18

Family

ID=27130325

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7908520A SE7908520L (en) 1978-10-17 1979-10-15 SYSTEM FOR ADMINISTRATION OF MEDICINAL PRODUCTS IN THE FORM OF MICROPARTICLES

Country Status (13)

Country Link
AU (1) AU528186B2 (en)
CA (1) CA1143289A (en)
CH (1) CH645545A5 (en)
DE (1) DE2940146A1 (en)
FR (1) FR2439014A1 (en)
GB (1) GB2034182B (en)
IE (1) IE48851B1 (en)
IL (1) IL58471A (en)
IT (1) IT1124572B (en)
NL (1) NL184723C (en)
NZ (1) NZ191837A (en)
PH (1) PH25638A (en)
SE (1) SE7908520L (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US5366734A (en) * 1981-02-16 1994-11-22 Zeneca Limited Continuous release pharmaceutical compositions
CH661206A5 (en) * 1983-09-23 1987-07-15 Debiopharm Sa PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF HORMONDEPENDENT DISEASES.
US4816257A (en) * 1985-09-20 1989-03-28 Research & Education Institute, Harbor-Ucla Medical Center Inc. Method for producing an in vivo environment suitable for human embryo transfer
US5688519A (en) * 1987-04-06 1997-11-18 Leonard; Robert J. Flash-flow fused medicinal implants
US5000886A (en) * 1987-05-26 1991-03-19 American Cyanamid Company Silicone-hardened pharmaceutical microcapsules and process of making the same
ATE87215T1 (en) * 1987-07-21 1993-04-15 Stolle Res & Dev METHOD OF OBTAINING IMMUNO-REGULATORY FACTORS USING MAMMALIAN IMMUNIZATION.
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
FR2620335A1 (en) * 1987-09-15 1989-03-17 Berdal Pascal PHARMACEUTICAL PRESENTATION POTENTIALIZING THE CYTOTROPHIC EFFECT OF SERUMS AND / OR ANTIBODY ANTIBODIES ANIMALS AND / OR HUMANS
US5084277A (en) * 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
US5922340A (en) 1992-09-10 1999-07-13 Children's Medical Center Corporation High load formulations and methods for providing prolonged local anesthesia
ATE267587T1 (en) 1995-06-09 2004-06-15 Euro Celtique Sa FORMULATIONS AND METHODS FOR PROLONGED LOCAL ANESTHESIA
AU733867B2 (en) 1996-06-24 2001-05-31 Euro-Celtique S.A. Methods for providing safe local anesthesia
US6046187A (en) 1996-09-16 2000-04-04 Children's Medical Center Corporation Formulations and methods for providing prolonged local anesthesia
AU739384B2 (en) 1997-07-02 2001-10-11 Euro-Celtique S.A. Prolonged anesthesia in joints and body spaces

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887699A (en) * 1969-03-24 1975-06-03 Seymour Yolles Biodegradable polymeric article for dispensing drugs
US3594468A (en) * 1969-04-01 1971-07-20 Vincent R Saurino Germicidal compositions
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US3875300A (en) * 1972-12-18 1975-04-01 Ortho Pharma Corp Composition for sustained release of a medicament and method of using same
AU513400B2 (en) * 1976-03-04 1980-11-27 Commonwealth Serum Laboratories Commission Biodegradable, sustained release composition

Also Published As

Publication number Publication date
NL184723B (en) 1989-05-16
IT1124572B (en) 1986-05-07
PH25638A (en) 1991-08-31
DE2940146A1 (en) 1980-04-30
NL7907432A (en) 1980-04-21
CA1143289A (en) 1983-03-22
AU5169679A (en) 1980-04-24
AU528186B2 (en) 1983-04-21
CH645545A5 (en) 1984-10-15
IE48851B1 (en) 1985-05-29
IE791966L (en) 1980-04-17
IL58471A (en) 1983-05-15
NL184723C (en) 1989-10-16
IT7926288A0 (en) 1979-10-05
DE2940146C2 (en) 1991-12-05
NZ191837A (en) 1984-07-31
FR2439014A1 (en) 1980-05-16
IL58471A0 (en) 1980-01-31
GB2034182B (en) 1983-07-27
FR2439014B1 (en) 1983-12-09
GB2034182A (en) 1980-06-04

Similar Documents

Publication Publication Date Title
SE7908520L (en) SYSTEM FOR ADMINISTRATION OF MEDICINAL PRODUCTS IN THE FORM OF MICROPARTICLES
DE3367732D1 (en) Device for introducing nutrients and/or therapeutic materials into ruminant animals
FI955124A (en) Mixture of veterinary medicinal products containing a proton pump inhibitor
ES321779A1 (en) A method for developing pharmaceutical compositions. (Machine-translation by Google Translate, not legally binding)
DE69004265D1 (en) DOSAGE FOR DELIVERY OF SOLUBLE OR INSOLUBLE MEDICINAL PRODUCTS.
Hawk et al. Uterine contractions in the ewe during progestagen-regulated oestrus
Boland et al. Comparison of control of oestrus and ovulation in sheep by an ear implant (SC-21009) or by intravaginal sponge (Cronolone or MAP)
US3664341A (en) Vaginal capsule
Rathbone et al. Controlled release intravaginal veterinary drug delivery
Pharriss et al. Steroid delivery systems for contraception
Gross A technique for sustained synchronization of hamster estrous cycles by hormonal means
Hawk Rapid disruption of sperm transport mechanisms by intra-uterine devices in the ewe
Cutler et al. Studies on development of a vaginal preparation providing both prophylaxis against venereal disease, other genital infections, and contraception. I. Venereal disease prophylaxis, past experience, present status and plans for future studies
Jarcho Artificial production of sterility: With special reference to experimental temporary sterility biologically induced in the female
Karp et al. The use of chlorpromazine in the obstetric patient; a preliminary report. II. The treatment of nausea and vomiting of labor and delivery with special reference to the effects on analgesia and anesthesia and on the newborn
Lippes et al. The loop, age 7 with five significant years of observation
Jakobsen The influence of oestrogenic hormones on the prostate; oestrogenic reactions in the human prostate after artificial hormone administration, in the normal human prostate at birth and in cases of senile hyperplasia of the prostate
Asch et al. Non-surgical expulsion of non-viable early pregnancy: a new application of RU 486
Barker Progestin impregnated vaginal pessaries for estrous cycle synchronization in sheep.
BROWN et al. The effect of plastic devices in the uterine lumen on pregnancy and parturition in the rabbit
Shelesnyak The production of deciduomata in immature rats by pituitary treatment
Ehrenpreis Tibia as donor area of bone grafts in infants, influence on the longitudinal growth: U. Breine and B. Johanson. Acta Chir. Scand. 131: 230–235, March 1966
Hendren Vaginal atresia: High transverse septum: AJ White. Obst. & Gynec. 27: 695–698, May 1966
Kunii Symposium on the chemotherapy of bacterial infection (2) Points at issue in the chemotherapy of bacterial infection in the field of internal medicine. ii) A study on the chemotherapy of biliary infection (author's transl
Vervat Giant ovarian cyst in a neonate: J. Koudstaal and HD Hamming. Nederl. T. Geneesk. 109: 82, 1966